Skip to main content
. 2012 Nov 21;75(6):1433–1444. doi: 10.1111/bcp.12042

Table 2.

Baseline haematology measurements for healthy subjects and patients with sickle cell disease

Measure Healthy subjects [n = 13; mean (SD)] Sickle cell disease [n = 13; mean (SD)] P value*
Haematocrit (%) 41 (5) 24 (3) <0.001
Haemoglobin (mmol l−1) 8.7 (1.0) 5.2 (0/5) <0.001
Neutrophils (×103 μl−1) 3.5 (1.5) 4.5 (1.4) 0.081
Mean cell volume (fl) 88.2 (3.4) 87.2 (15.0) 0.817
Erythrocyte count (×106 μl−1) 4.7 (0.5) 2.8 (0.7) <0.001
Leucocytes (×103 μl−1) 6.0 (2.0) 9.6 (2.7) <0.001
Lymphocytes (×103 μl−1) 1.8 (0.5) 3.6 (1.3) <0.001
Monocytes (×103 μl−1) 0.5 (0.1) 1.2 (0.5) <0.001
Eosinophils (×103 μl−1) 0.2 (0.1) 0.3 (0.2) 0.095
Basophils (×103 μl−1) 0.02 (0.04) 0.04 (0.05) 0.199
Platelets (×103 μl−1) 234.6 (50.0) 375.8 (112.6) <0.001
Mean platelet volume (fl) 10.4 (0.7) 10.1 (0.8) 0.198
MCHC (mmol l−1-Fe) 21.1 (0.6) 21.8 (0.6) 0.003
Reticulocyte count (×103 μl−1) 43.6 (28.7) 252.8 (120.1) <0.001
Prothrombin time (s) 11.1 (0.6) 11.5 (0.7) 0.099
APTT (s) 28.1 (1.7) 25.2 (2.0) <0.001
Platelet distribution index 12.2 (1.5) 11.0 (1.4) 0.034

Abbreviations are as follows: APTT, activated partial thromboplastin time; and MCHC, mean cell haemoglobin concentration.

*

P values are from Student's unpaired t-test.